triazoles has been researched along with pyrazole in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 18 (69.23) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Fotsch, C; St Jean, DJ | 1 |
| Kulys, J; Tetianec, L; Ziemys, A | 1 |
| Cheng, L; Xie, R; You, J; Zhang, Y; Zhu, L | 1 |
| Kruse, CG; Lange, JH | 1 |
| Bacilieri, M; Bolcato, C; Cacciari, B; Cardin, R; Federico, S; Kachler, S; Klotz, KN; Michielan, L; Moro, S; Pastorin, G; Spalluto, G; Sperduti, A | 1 |
| Keith, JM | 1 |
| HAMILTON, CS; SHARP, DB | 1 |
| Behbehani, H; Ibrahim, HM; Mahmoud, H; Makhseed, S | 1 |
| Cheong, SL; Federico, S; Paira, P; Pastorin, G; Shao, YM; Spalluto, G; Venkatesan, G; Yap, CW | 1 |
| Cui, JR; Cui, ZN; Li, BJ; Ling, Y; Shi, YX; Yang, XL | 1 |
| Cañon-Mancisidor, W; Paredes-Garcia, V; Spodine, E; Venegas-Yazigi, D | 1 |
| Fun, HK; Isloor, AM; Shetty, P; Sundershan, S; Vijesh, AM | 1 |
| Atwal, K; Blanar, M; Caringal, Y; Conder, ML; Finlay, HJ; Harper, T; Hsueh, MM; Jiang, J; Kover, A; Levesque, P; Lloyd, J; Wexler, R; Xing, D | 1 |
| Abdel-Megeid, RE; Ali, HS; Rashad, AE; Shamroukh, AH | 1 |
| Al-Harbi, NO; Amr, Ael-G; Bahashwan, SA; Fayed, AA; Ramadan, MA | 1 |
| Chernova, NP; Khlebnikov, AI; Ogorodnikov, VD; Petrenko, TV; Potapov, AS | 1 |
| Boesen, T; Claesson, HE; Forsell, P; Groth, T; Hallberg, A; Krog-Jensen, C; Kromann, H; Larhed, M; Nilsson, P; No, K; Öhrman, S; Pelcman, B; Sanin, A; Schaal, W; Vogensen, SB | 1 |
| Atmakur, K; Bingi, C; Emmadi, NR; Kotapalli, SS; Nanubolu, JB; Ummanni, R | 1 |
| Hornum, M; Kumar, P; Nielsen, P; Podsiadly, P | 1 |
| Bhatt, JD; Chudasama, CJ; Patel, KD | 1 |
| Camarco, DP; Colombo, R; Garzan, A; Grandis, JR; Hua, Y; Huryn, DM; Johnston, PA; LaPorte, MG; Lazo, JS; Liang, M; Peshkov, VA; Pollock, NI; Schurdak, ME; Sen, M; Wang, Z; Wipf, P | 1 |
| Ben Jannet, H; Chekir, S; Dargère, D; Debbabi, M; Gharbi, R; Laprévote, O; Regazzetti, A | 1 |
| Bagnarelli, L; Gandin, V; Marchiò, L; Marzano, C; Pellei, M; Santini, C | 1 |
| Abdellatif, KRA; Elshaier, YAMM; Fadaly, WAA; Hassanein, EHM | 1 |
| Caravana, AC; Dhanju, S; Thomson, RJ | 1 |
| Abdelall, EKA; Abdellatif, KRA; Elshemy, HAH; Hassanein, EHM; Kahk, NM; Philoppes, JN | 1 |
1 review(s) available for triazoles and pyrazole
| Article | Year |
|---|---|
Mitigating heterocycle metabolism in drug discovery.
Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats | 2012 |
25 other study(ies) available for triazoles and pyrazole
| Article | Year |
|---|---|
Probing Aspergillus niger glucose oxidase with pentacyanoferrate(III) aza- and thia-complexes.
Topics: Aspergillus niger; Benzimidazoles; Ferric Compounds; Glucose Oxidase; Histidine; Imidazoles; Models, Chemical; Models, Molecular; Oxidation-Reduction; Pyrazoles; Pyridines; Structure-Activity Relationship; Thiadiazoles; Triazoles | 2006 |
Highly efficient copper-catalyzed N-arylation of nitrogen-containing heterocycles with aryl and heteroaryl halides.
Topics: Catalysis; Copper; Hydrocarbons, Halogenated; Imidazoles; Iodides; Molecular Structure; Nitrogen; Pyrazoles; Pyrroles; Triazoles | 2007 |
Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives.
Topics: Animals; Anti-Obesity Agents; CHO Cells; Cricetinae; Cricetulus; Humans; Imidazoles; Isomerism; Models, Chemical; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Solubility; Structure-Activity Relationship; Thiazoles; Triazoles; Water | 2008 |
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.
Topics: Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Artificial Intelligence; Binding Sites; Drug Discovery; Humans; Models, Chemical; Protein Binding; Pyrazoles; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Static Electricity; Structure-Activity Relationship; Triazoles | 2009 |
One-step conversion of azine N-oxides to alpha-1,2,4-triazolo-, 1,2,3-triazolo, imidazolo-, and pyrazoloheteroarenes.
Topics: Cyclic N-Oxides; Imidazoles; Pyrazoles; Triazoles | 2010 |
Derivatives of 1,2,4-triazole and of pyrazole.
Topics: Pyrazoles; Triazoles | 1946 |
Applications of 2-arylhydrazononitriles in synthesis: preparation of new indole containing 1,2,3-triazole, pyrazole and pyrazolo[1,5-a]pyrimidine derivatives and evaluation of their antimicrobial activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Molecular Structure; Nitriles; Pyrazoles; Pyrimidines; Saccharomyces cerevisiae; Stereoisomerism; Triazoles | 2011 |
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonists.
Topics: Adenosine A3 Receptor Antagonists; Humans; Models, Molecular; Molecular Structure; Protein Binding; Pyrazoles; Pyrimidines; Quantitative Structure-Activity Relationship; Triazoles | 2011 |
Synthesis and bioactivities of novel pyrazole and triazole derivatives containing 5-phenyl-2-furan.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Fungicides, Industrial; Furans; Humans; Phytophthora; Pyrazoles; Structure-Activity Relationship; Triazoles | 2012 |
Theoretical description of the magnetic properties of μ3-hydroxo bridged trinuclear copper(II) complexes.
Topics: Copper; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; Magnetics; Molecular Structure; Pyrazoles; Triazoles | 2013 |
New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzoxazoles; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Pain; Pain Measurement; Pyrazoles; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 2013 |
Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists.
Topics: Animals; Cell Line; Imidazoles; Isomerism; Kv1.5 Potassium Channel; Mice; Potassium Channel Blockers; Potassium Channels; Protein Binding; Pyrazoles; Pyrimidines; Structure-Activity Relationship; Triazoles | 2013 |
Synthesis and isomerization of some novel pyrazolopyrimidine and pyrazolotriazolopyrimidine derivatives.
Topics: Isomerism; Molecular Structure; Pyrazoles; Pyrimidines; Structure-Activity Relationship; Triazoles | 2014 |
Androgen receptor antagonists and anti-prostate cancer activities of some newly synthesized substituted fused pyrazolo-, triazolo- and thiazolo-pyrimidine derivatives.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; CHO Cells; Cricetulus; Humans; Lethal Dose 50; Male; Prostatic Neoplasms; Pyrazoles; Pyrimidines; Thiazoles; Triazoles | 2014 |
Facile synthesis of pyrazole- and benzotriazole-containing selenoethers.
Topics: Chemistry, Organic; Crystallography, X-Ray; Ether; Molecular Conformation; Pyrazoles; Selenium; Triazoles | 2014 |
3-Substituted pyrazoles and 4-substituted triazoles as inhibitors of human 15-lipoxygenase-1.
Topics: Arachidonate 15-Lipoxygenase; Benzoxazoles; Humans; Lipoxygenase Inhibitors; Pyrazoles; Structure-Activity Relationship; Triazoles | 2015 |
Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Click Chemistry; Halogenation; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Pyrazoles; Structure-Activity Relationship; Triazoles | 2015 |
Increasing the Stability of DNA:RNA Duplexes by Introducing Stacking Phenyl-Substituted Pyrazole, Furan, and Triazole Moieties in the Major Groove.
Topics: Circular Dichroism; Deoxyuridine; DNA; Furans; Models, Molecular; Nucleic Acid Conformation; Oligonucleotides; Pyrazoles; RNA; Triazoles | 2015 |
Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Chlorocebus aethiops; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrazoles; Pyrimidines; Triazoles; Tuberculosis; Vero Cells | 2015 |
Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrazoles; STAT3 Transcription Factor; Structure-Activity Relationship; Thiadiazines; Triazoles | 2016 |
Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
Topics: Alkynes; Antineoplastic Agents; Azides; Catalysis; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Copper; Coumarins; Cycloaddition Reaction; Drug Design; Humans; Inhibitory Concentration 50; Lipoxygenase Inhibitors; Monophenol Monooxygenase; Pyrazoles; Structure-Activity Relationship; Triazoles | 2018 |
Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands.
Topics: Cell Death; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Copper; Crystallography, X-Ray; Humans; Ligands; Models, Molecular; Molecular Structure; Pyrazoles; Spheroids, Cellular; Triazoles | 2019 |
New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide relea
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Models, Molecular; Molecular Structure; Nitric Oxide; Oximes; PC-3 Cells; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship; Triazoles | 2020 |
Access to α-Pyrazole and α-Triazole Derivatives of Ketones from Oxidative Heteroarylation of Silyl Enolethers.
Topics: Cerium; Ketones; Molecular Structure; Oxidation-Reduction; Pyrazoles; Triazoles | 2020 |
Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and mol
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiotonic Agents; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Edema; Inflammation; Male; Models, Molecular; Molecular Structure; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship; Triazoles | 2021 |